Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(124 ratings | avg ★ 4.6)
App Store (124 ratings)
Last 28 days
Revenue
$1,265
AR
$15,180
MRR
$2,661
ARR
$31,932
Cash Flow Index
0.5x
Active Subscriptions
2,038
Active Trials
5
ARPAS
$0.62
Paid Subscriber Share (snapshot)
99.8%
Active Customers
951
New Customers
195
Subscription Penetration
214.3%
ARPU
$1.33
RPD
$1.33
ARPPU
$1.31
LTV
$13
MRR Growth (28d)
-5.7%
Revenue Growth (28d)
-6.5%
Subscriber Growth (28d)
-3.3%
All data is verified through RevenueCat. Last updated: Feb 2, 2026, 12:30:38 AM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$53,220
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗-strive
FOR SALELast 30 days rev
$13,620
MRR
$10,992
FitCal
FOR SALELast 30 days rev
$9,996
MRR
$6,616
Tokhub
FOR SALELast 30 days rev
$90
MRR
—
SmokeCount
FOR SALELast 30 days rev
$79
MRR
$28
Snap Cal
FOR SALELast 30 days rev
$65
MRR
$138
CalBuddy
Last 30 days rev
$51,288
MRR
$12,422




